Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 4:55 pm Purchase | 13G | DELCATH SYS INC DCTH | Altium Capital Management LP | 134,069 9.9% | 134,069 (New Position) | View |
2020-02-14 4:08 pm Sale | 13G | IMMUTEP LTD SPONSORED ADR IMMP | Altium Capital Management LP | 2,000,000 6.4% | -248,000,000 (-99.20%) | View |
2020-02-14 3:46 pm Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Altium Capital Management LP | 349,846 8.5% | 96,973 (+38.35%) | View |
2020-02-14 3:39 pm Unchanged | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Altium Capital Management LP | 1,546,082 9.9% | 0 (Unchanged) | View |
2020-02-14 1:51 pm Unchanged | 13G | REGULUS THERAPEUTICS INC RGLS | Altium Capital Management LP | 3,229,780 9.99% | 0 (Unchanged) | View |
2020-02-14 1:33 pm Purchase | 13G | ONCOSEC MED INC PAR $0.000 ONCS | Altium Capital Management LP | 714,000 4.99% | 714,000 (New Position) | View |
2020-02-14 1:23 pm Unchanged | 13G | AYTU BIOSCIENCE INC AYTU | Altium Capital Management LP | 5,000,000 9.9% | 0 (Unchanged) | View |
2020-02-14 1:18 pm Sale | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Altium Capital Management LP | 56,000 1.1% | -16,610,600 (-99.66%) | View |
2020-02-14 11:54 am Unchanged | 13G | ORAMED PHARMACEUTICALS INC. NE ORMP | Altium Capital Management LP | 972,000 4.99% | 0 (Unchanged) | View |
2020-02-14 10:20 am Sale | 13G | SAVARA INC SVRA | Altium Capital Management LP | 0 0% | -2,368,000 (Position Closed) | View |
2020-02-14 10:14 am Sale | 13G | SEELOS THERAPEUTICS INC SEEL | Altium Capital Management LP | 0 0% | -228,676 (Position Closed) | View |
2020-02-13 4:08 pm Sale | 13G | XENETIC BIOSCIENCES INC PA XBIO | Altium Capital Management LP | 0 0% | -260,000 (Position Closed) | View |
2020-02-13 4:06 pm Sale | 13G | ADVAXIS INC PAR $0.001 ADXS | Altium Capital Management LP | 0 0% | -2,142,750 (Position Closed) | View |
2020-02-13 2:16 pm Sale | 13G | ALLENA PHARMACEUTICALS COM ALNA | Altium Capital Management LP | 0 0% | -2,340,136 (Position Closed) | View |
2020-02-10 10:09 am Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Altium Capital Management LP | 925,000 7.4% | 925,000 (New Position) | View |
2019-12-31 3:37 pm Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | Altium Capital Management LP | 3,229,780 9.99% | 1,901,979 (+143.24%) | View |
2019-11-25 3:34 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Altium Capital Management LP | 1,546,082 9.9% | 1,546,082 (New Position) | View |
2019-10-21 5:01 pm Purchase | 13G | AYTU BIOSCIENCE INC AYTU | Altium Capital Management LP | 5,000,000 9.9% | 5,000,000 (New Position) | View |
2019-07-31 1:33 pm Purchase | 13G | ADVAXIS INC PAR $0.001 ADXS | Altium Capital Management LP | 2,142,750 9.87% | 2,142,750 (New Position) | View |
2019-07-25 4:53 pm Purchase | 13G | XENETIC BIOSCIENCES INC PA XBIO | Altium Capital Management LP | 260,000 9.8% | 260,000 (New Position) | View |